FASN and neoplasm: Even though multiple studies demonstrate that inhibition of FASN decreases CRC cell growth and survival in vitro, pre-clinical studies demonstrate much less efficacy of FASN inhibition on tumor growth in vivo, potentially due to compensation mechanisms such as dietary fatty acid uptake [9,21].